Q2 2026 13F · SEC CIK 1649186
Prostatis Group LLC
Wealth managerFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $429.4M
- Reported positions
- 190
- Holdings vs S&P 500, 3 yrs
- —
- Assets under management
- $605.4M
Prostatis Group LLC is a wealth manager that reported 190 positions worth $429.4M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Thor Finl Technologies Tr (THIR, 16.8%), Amplify ETF Tr (DIVO, 4.9%), Invesco Qqq Tr (QQQ, 3.9%).
Prostatis Group LLC holdings largest 50 of 190 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Prostatis Group LLC bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
- VUG Vanguard Index Fds+489.7% shares
- BIL Spdr Series Trust+87.3% shares
- EWQ Ishares Inc+38.4% shares
- EWG Ishares Inc+36.4% shares
- IAI Ishares Tr+32.6% shares
- RSP Invesco Exchange Traded Fd T+29.7% shares
- EWI Ishares Inc+29.0% shares
- SPHD Invesco Exch Traded Fd Tr II+17.0% shares
Reduced
- PVAL Putnam Focused Large Capvalue ETF-52.9% shares
- XNTK Spdr Series Trust-29.5% shares
- VOX Vanguard Telecommunication Ser-24.8% shares
- AIED Exchange Listed Fds Tr-22.3% shares
- QQQ Invesco Qqq Tr-20.0% shares
- NVDA Nvidia Corporation-18.3% shares
- IGM Ishares Tr-17.2% shares
- IYW Ishares Tr-10.1% shares
Left the top 50
- IYG Ishares Trwas 1.0%
- VCIT Vanguard Scottsdale Fdswas 1.0%
- EWY Ishares Incwas 0.9%
- EWU Ishares Trwas 0.9%
- EWJ Ishares Incwas 0.9%
- XAR State Streerwas 0.9%
- XHB Spdr Series Trustwas 0.8%
- ITB Ishares Trwas 0.5%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +19.4% /yr
- S&P 500 +20.1%
- 3 years
- —
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $429.4M | 190 |
| Q1 2026 | $390.7M | 167 |
| Q4 2025 | $418.8M | 165 |
| Q3 2025 | $399.0M | 165 |
| Q2 2025 | $349.4M | 156 |
| Q1 2025 | $317.0M | 151 |
| Q4 2024 | $343.1M | 155 |
| Q3 2024 | $305.6M | 130 |
| Q2 2023 | $215.0M | 250 |
| Q1 2023 | $189.4M | 98 |
| Q4 2022 | $163.9M | 97 |
| Q3 2022 | $86.8M | 64 |
Questions about Prostatis Group LLC's portfolio
What stocks does Prostatis Group LLC own?
Prostatis Group LLC's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 190 positions worth $429.4M. The largest are Thor Finl Technologies Tr (THIR) at 16.8%, Amplify ETF Tr (DIVO) at 4.9%, Invesco Qqq Tr (QQQ) at 3.9%, Vanguard Index Fds (VUG) at 2.8% and Ishares Tr (IGM) at 2.7%.
What did Prostatis Group LLC buy last quarter?
In Q2 2026, Prostatis Group LLC added Vanguard Index Fds (VUG) (+489.7% shares), Spdr Series Trust (BIL) (+87.3% shares) and Ishares Inc (EWQ) (+38.4% shares), compared with its Q1 2026 filing.
What did Prostatis Group LLC sell last quarter?
In Q2 2026, Prostatis Group LLC cut from its top 50 Ishares Tr (IYG), cut from its top 50 Vanguard Scottsdale Fds (VCIT), cut from its top 50 Ishares Inc (EWY), cut from its top 50 Ishares Tr (EWU), cut from its top 50 Ishares Inc (EWJ), Putnam Focused Large Capvalue ETF (PVAL) (-52.9% shares), Spdr Series Trust (XNTK) (-29.5% shares) and Vanguard Telecommunication Ser (VOX) (-24.8% shares), compared with its Q1 2026 filing.
When is Prostatis Group LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. Prostatis Group LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Prostatis Group LLC manage?
Prostatis Group LLC reported $605.4M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $429.4M.